Cover Image
市場調查報告書

免疫檢測的全球市場 (感染疾病、腫瘤標記(癌症篩檢)、甲狀腺、過敏、藥物濫用、治療藥監測等)

Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others)

出版商 Kalorama Information 商品編碼 290787
出版日期 內容資訊 英文 470 Pages
訂單完成後即時交付
價格
Back to Top
免疫檢測的全球市場 (感染疾病、腫瘤標記(癌症篩檢)、甲狀腺、過敏、藥物濫用、治療藥監測等) Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others)
出版日期: 2017年09月06日 內容資訊: 英文 470 Pages
簡介

本報告提供全球免疫檢測市場相關分析,技術概要和市場基本結構,近來的技術、市場趨勢 (實驗室的各類型、各疾病分類),今後主要的機會與課題,市場規模的變化及預測,主要企業簡介 (共149家公司) 等調查。

第1章 摘要整理

第2章 簡介

第3章 技術、趨勢、創新

  • 概要:免疫檢測 (ELISA法,放射線免疫檢測)
  • 概要:設備的平台
    • 自動化
    • 平台的技術創新:小型化,微小液體,多重檢測
  • 檢驗樣品:血液,尿,唾液

第4章 市場區隔:實驗室 (檢驗室)的各類型

  • 集中型實驗室
  • 迅速、照護現場 (POC) 檢驗
    • 醫院的POC檢驗
    • 開業醫生,實驗室,診所
    • 快速門診
    • 其他專門POC檢驗
    • 自我檢驗
    • 銷售POC檢驗用免疫檢測的企業
  • 血液檢驗

第5章 免疫檢測診斷市場上活動:各疾病分類

  • 感染疾病
    • 肝炎
    • 反轉錄病毒
    • 性感染疾病
    • TORCH症候群
    • 其他感染疾病:在集中檢驗室的免疫檢測
    • 迅速、POC檢驗
    • 血液檢驗
  • 腫瘤標記(癌症篩檢)
  • 心臟標記
  • 不孕/妊娠/生殖荷爾蒙
  • 甲狀腺
  • 代謝障礙、其他荷爾蒙
  • 治療藥監測
  • 藥物濫用
  • 過敏
  • 自體免疫疾病
  • 免疫檢測診斷市場上其他的疾病分類

第6章 免疫檢測的市場機會、課題

  • 免疫檢測市場:市場成長的促進要素、課題
  • 免疫檢測相關在新領域的技術創新
    • 消化器官疾病
    • 移植管理
    • 妊娠毒血症
    • 阿茲海默症
  • 新興國家市場
  • 免疫檢測市場未來展望

第7章 免疫檢測市場分析

  • 市場概要與區分
    • 中央實驗室為基礎的免疫檢測市場
    • POC (照護現場) 免疫檢測市場
    • 血液檢驗用免疫檢測市場
    • 免疫檢測市場:各產品種類
    • 免疫檢測市場:各技術種類
  • 市場競爭分析
  • 實驗室型免疫檢測:各疾病分類
  • POC/迅速免疫檢測:各疾病分類
  • 免疫檢測市場:各地區
    • 歐洲,其他
  • 免疫檢測市場成長預測

第8章 企業簡介

  • 1 STEP DETECT ASSOCIATES, LLC
    • 企業概要,主要產品,財務指標
  • ABBOTT LABORATORIES
  • ABINGDON HEALTH, LTD.
  • ACCESS BIO, INC.
  • ACCUBIOTECH CO, LTD.
  • ACCUTECH, LLC
  • ACON LABORATORIES, INC
  • AESKU. DIAGNOSTICS
  • AKERS BIOSCIENCES, INC.
  • ALERE INC.
  • ALFA SCIENTIFIC DESIGNS, INC
  • AMERICAN LABORATORY PRODUCTS COMPANY (ALPCO)
  • AMERICAN BIO MEDICA CORPORATION
  • AMNISURE INTERNATIONAL
  • ARK DIAGNOSTICS, INC.
  • Arkray
  • ARLINGTON SCIENTIFIC, INC.
  • ARTRON LABORATORIES INC.
  • ASSOCIATES OF CAPE COD, INC. (ACC)
  • ASTRA BIOTECH GMBH
  • ATLAS GENETICS LTD.
  • ATLAS LINK BIOTECH CO., LTD
  • AUDIT DIAGNOSTICS
  • AUGURIX DIAGNOSTIC
  • AUTOBIO DIAGNOSTICS CO., LTD
  • AVIOQ, INC.
  • AWARENESS TECHNOLOGY
  • AXA DIAGNOSTICS S.R.L.
  • AXIS SHIELD DIAGNOSTICS LTD.
  • BECKMAN COULTER, INC
  • BECTON DICKINSON (BD)
  • BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
  • BG MEDICINE, INC.
  • BHAT BIO-TECH INDIA PRIVATE LTD. (BBI)
  • BINDING SITE GROUP LTD.
  • BIOCARE DIAGNOSTICS LTD.
  • BIOCHECK, INC
  • BIOHIT OYJ (BIOHIT HEALTHCARE)
  • BIOKIT S.A.
  • BIOLYTICAL LABORATORIES
  • BIOMERICA
  • BIOMERIEUX SA
  • BIOPORTO DIAGNOSTICS
  • BIO-RAD LABORATORIES INC
  • BIOSCAN SCREENING SYSTEMS, INC.
  • BIOSCIENCE (TIANJIN) DIAGNOSTIC TECHNOLOGY CO., LTD.
  • BIOTECH ATLANTIC, INC.
  • BIO-TECHNE
  • BIOTRON DIAGNOSTICS, INC.
  • BNTX INC.
  • BOSON BIOTECH CO. LTD
  • BUHLMANN LABORATORIES AG
  • CALYPTE BIOMEDICAL CORPORATION
  • CARE PRODUCTS, INC.
  • CERTEST BIOTEC
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
  • CISBIO BIOASSAYS
  • CLARITY DIAGNOSTICS, LLC
  • CONFIRM BIOSCIENCES
  • CTK BIOTECH, INC.
  • DIAGENICS LTD.
  • DIALAB GMBH
  • DIAMETRA
  • DIASORIN S.P.A.
  • DIASOURCE IMMUNOASSAYS SA
  • DIASYS DIAGNOSTIC SYSTEMS GMBH
  • DIAXOHIT
  • DIAZYME LABORATORIES, INC.
  • DR. FOOKE-ACHTERRATH LABORATORIEN GMBH
  • DRG INTERNATIONAL, INC.
  • 榮研化學
  • EKF DIAGNOSTICS HOLDINGS PLC
  • ELITECHGROUP, INC.
  • ERBA DIAGNOSTICS, INC.
  • EUROIMMUN AG
  • EUROSPITAL S.P.A.
  • EY LABORATORIES
  • FIRST CHECK DIAGNOSTICS LLC
  • FUJIREBIO US, INC.
  • GENBIO
  • GETEIN BIOMEDICAL, INC.
  • GLYSBY SNC
  • GOLD STANDARD DIAGNOSTICS
  • GRIFOLS INTERNATIONAL S.A.
  • HEMA DIAGNOSTIC SYSTEMS, LLC
  • HEMOSURE, INC.
  • HOB BIOTECH
  • HYCOR BIOMEDICAL, INC.
  • IMMUNODIAGNOSTIC SYSTEMS LTD. (IDS)
  • IMMUNO-MYCOLOGICS, INC.
  • IMMUNOSCIENCES LAB, INC.
  • IMMUNOSTICS, INC
  • INBIOS INTERNATIONAL, INC.
  • INOVA DIAGNOSTICS, INC
  • JANT PHARMACAL CORPORATION
  • KRONUS
  • LABSYSTEMS DIAGNOSTICS OY
  • LIFESIGN, LLC
  • LUMINEX CORPORATION
  • MEDIX BIOCHEMICA
  • MEDMIRA, INC
  • MERCODIA AB
  • MERIDIAN BIOSCIENCE, INC
  • MONOBIND, INC
  • NANO-DITECH CORPORATION
  • NOVA BIOMEDICAL, CORP.
  • NOVATEC IMMUNODIAGNOSTICA GMBH
  • OASIS DIAGNOSTICS CORPORATION
  • ONCIMMUNE HOLDINGS PLC.
  • ONE LAMBDA
  • OPERON
  • OPKO HEALTH, INC
  • ORASURE TECHNOLOGIES, INC.
  • ORGENTEC DIAGNOSTIKA GMBH
  • ORION DIAGNOSTICA OY
  • ORTHO CLINICAL DIAGNOSTICS
  • POLYMEDCO, INC
  • QUALIGEN, INC.
  • QUANTERIX CORPORATION
  • QUIDEL CORPORATION
  • PREVENTIS GMBH
  • PRINCETON BIOMEDITECH CORPORATION
  • PROTAGEN AG
  • RADIOMETER MEDICAL A/S
  • RANDOX LABORATORIES LTD.
  • RELIA DIAGNOSTICS, INC
  • RENESA UG
  • RESPONSE BIOMEDICAL CORP
  • RESZON DIAGNOSTICS INTERNATIONAL SDN. BHD.
  • ROCHE DIAGNOSTIC CORPORATION
  • SAVYON DIAGNOSTICS LTD.
  • SEKISUI DIAGNOSTICS
  • SIEMENS HEALTHINEERS
  • SINGULEX, INC
  • STANDARD DIAGNOSTICS, INC.
  • SYNTRON BIORESEARCH, INC.
  • TECHLAB, INC.
  • TECO DIAGNOSTICS
  • THERADIAG
  • THERMO FISHER SCIENTIFIC, INC
  • Tosoh (TOSOH BIOSCIENCE, INC.)
  • TRINITY BIOTECH PLC
  • TRUE DIAGNOSTICS
  • VIRCELL
  • VOLITIONRX LIMITED
  • WAKO DIAGNOSTICS
  • WAMA DIAGNOSTICA
  • WERFEN GROUP
  • ZEUS SCIENTIFIC, INC.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI15468656

The immunoassay market is a large, well-established market with billions in sales. This market consists of three major segments: immunoassays performed in centralized laboratories for clinical indications such as screening, diagnosis, and/or monitoring patients, point-of-care or rapid immunoassays also performed for clinical indications, and immunoassays performed to screen the blood supply to prevent transfusion-transmitted infections.

Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance (an analyte). Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of types of immunoassays is now used to measure proteins (including antibodies), hormones, drugs, and other analytes. Fully automated immunoassay systems are now found in clinical laboratories. Even though the field of immunoassays is now mature, companies have continued to develop new immunoassays and immunoassay instrument platforms to improve the sensitivity of the assays. New developments are designed to make multiplexing possible, to miniaturize the platforms for point-of care, and to identify and develop assays for novel biomarkers, thus further expanding the potential of immunoassays for the future.

This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data:

  • Global Immunoassay Market, 2017-2021
  • Historical Market 2014-2016
  • ELISA Markets
  • Radioimmunoassay Markets
  • Lab-based Immuonassay Markets
  • POC Immumonassays
  • Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease)
  • Tumor Marker Immunoassays
  • Thyroid
  • Metabolic and Other Hormone Immunoassays
  • Therapeutic Drug Monitoring Immunoassays
  • Drugs of Abuse Immunoassays
  • Transplant Medicine, IBD, Alzheimer's and Other Areas of Disease Innovation
  • Instrument Platforms
  • International and Emerging Markets
  • Company Profiles

Prospects for growth in the immunoassay market are good in certain geographical regions of the world (developing countries). Several factors are driving the growth of diagnostic testing, including testing with lateral flow devices, in these markets. One major factor is economics. There is a growing middle class population that is increasingly insured in many countries in South East Asia and Latin America, and these patients are better able to pay for services. In addition, increased availability of health insurance in emerging companies such as China and India is helping to fuel this growth. These and other factors will make these regions promising segments of the immunoassay market. The report provides more specific data regarding immunoassay growth.

The central lab-based immunoassays market is by far the largest segment of the total immunoassay market with 70.6% of this market in 2016. Centralized laboratories include reference laboratories (such as Laboratory Corporation of America or LabCorp, Quest Diagnostics, and others), hospital laboratories, laboratories operated by health maintenance organizations (HMOs), and other centralized laboratories. These laboratories range from very high volume labs down to smaller labs, but they typically use the fully automated immunoassay and chemistry/immunoassay analyzers discussed in the report for their high volume immunoassay tests. They may also have other platforms for tests that are not as high volume, and therefore are not on the fully automated platforms.

The market for point-of-care (POC) testing consists of two segments, self-testing (also referred to as the over-the-counter or OTC segment), and professional POC testing. However, there are many locations where POC testing can occur within these segments, especially the professional POC market. Professional POC testing is performed in a number of different settings including in hospitals, physicians office laboratories (POLs) and clinics, retail clinics, and many other locations.

Immunoassays also play a role in blood testing (or blood screening) market, which represents only 3.5% of the total immunoassay market. In developed countries, all units of blood and blood products are already screened for several infectious agents. Growth of the blood testing market in these countries is primarily driven by changes in the numbers of units donated and being screened. An exception and potentially significant step increase in the size of this market could occur if it is mandated that a new (additional) immunoassay be used to screen blood for an additional disease. In some developing countries, not all units of blood and blood products are screened for every recommended infectious agent. Additional growth could occur in these markets as more of the blood supply is screened. However, Kalorama expects that the overall, worldwide market for immunoassays used to screen blood will continue to grow slowly.

Market data in this report are based on factory sales to the end user, and not on retail pricing or reimbursement payments. The dollar value of a market segment is proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.

Table of Contents

1: EXECUTIVE SUMMARYOVERVIEW

  • SCOPE AND METHODOLOGY
  • MARKET OVERVIEW
    • Table 1-1: Global Immunoassay Market 2014-2021(in millions % at manufacturer level)
  • COMPETITIVE SUMMARY
  • FUTURE PROSPECTS IN THE IMMUNOASSAY MARKET

2: INTRODUCTION

  • HISTORY AND FUTURE OF IMMUNOASSAYS
  • POINT OF VIEW

3: TECHNOLOGY, TRENDS AND INNOVATIONS

  • OVERVIEW - IMMUNOASSAYS
  • ELISA
    • Radioimmunoassays
  • OVERVIEW - INSTRUMENT PLATFORMS
    • Automation
    • Platform Innovations - Miniaturization, Microfluidics and Multiplexed Assays
      • Table 3-1: Selected Innovations in Immunoassay PlatformsSPECIMEN TYPESBlood
    • Urine
    • Saliva
      • Table 3-2: Selected Companies with Saliva or Oral-Fluid Collection Devices

4: MARKET SEGMENT BY TYPE OF LABORATORY

  • CENTRALIZED LABORATORIES
    • Companies Marketing to Centralized Laboratories
      • Table 4-1: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide
  • RAPID AND POINT-OF-CARE TESTING
    • POC Testing in Hospitals
    • Physician's Office Laboratories and Clinics
    • Retail Clinics
    • Other Professional POC Testing
    • Self-Testing
    • Companies Marketing Immunoassay for POC Testing
      • Table 4-2: Selected Companies Marketing Immunoassay sand/or Lateral Flow Tests for POC Worldwide
  • BLOOD TESTING
    • Table 4-3: Selected Companies Marketing Immunoassay Platforms for Blood Screening Worldwide

5: IMMUNOASSAY DIAGNOSTIC MARKET ACTIVITY BY DISEASE CATEGORY

  • Table 5-1: Immunoassay Market Disease Categories
  • INFECTIOUS DISEASE
    • Hepatitis
    • Retroviral
    • Sexually Transmitted Diseases
  • TORCH
    • Other Infectious Diseases -Immunoassays in Central Laboratories
    • Rapid and POC Testing
    • Blood Testing
      • Table 5-2: Selected Infectious Disease Immunoassays
      • Table 5-3: Selected Companies Marketing Immunoassasys for Infectious Disease
  • TUMOR MARKERS
    • Table 5-4: Selected Tumor Marker Immunoassays
    • Table 5-5: Selected Companies Marketing Immunoassasys for Tumor Markers
  • CARDIAC MARKERS
    • Table 5-6: Selected Cardiac Marker Immunoassays
    • Table 5-7: Selected Companies Marketing Immunoassasys for Cardiac Markers
  • FERTILITY/PREGNANCY/REPRODUCTIVE HORMONES
    • Table 5-8: Selected Fertility and Reproductive Hormone Immunoassays
    • Table 5-9: Selected Companies Marketing Immunoassasys for Fertility/Pregnancy/Reproductive Hormone Diagnostics
  • THYROID
    • Table 5-10: Selected Thyroid Hormone Immunoassays
    • Table 5-11: Selected Companies Marketing Immunoassasys for Thyroid Hormone Diagnostics
  • METABOLIC DISORDERS AND OTHER HORMONES
    • Table 5-12: Selected Metabolic and Other Hormone Immunoassays
    • Table 5-13: Selected Companies Marketing Metabolic and Other Immunoassasys
  • THERAPEUTIC DRUG MONITORING
    • Table 5-14: Selected Therapeutic Drug Monitoring Immunoassays
    • Table 5-15: Selected Companies Marketing Immunoassasys for Therapeutic Drug Monitoring
  • DRUGS OF ABUSE
    • Table 5-16: Selected Drugs of Abuse Immunoassays
    • Table 5-17: Selected Companies Marketing Immunoassays for Drugs of Abuse
  • ALLERGY
    • Table 5-18: Selected Allergy Immunoassays (Does not include all companies marketing allergy tests)
    • Table 5-19: Selected Companies Marketing Immunoassays for Allergy Diagnostics
  • AUTOIMMUNE DISEASE
    • Table 5-20: Selected Autoantibodies Detected by Autoimmune Immunoassays
    • Table 5-21: Selected Companies Marketing Immunoassays for Autoimmune Disease
  • OTHER DISEASE CATEGORIES IN IMMUNOASSAY DISEASE MARKET
    • Table 5-22: Selected Other Immunoassays

6: MARKET OPPORTUNITIES AND ISSUES FOR IMMUNOASSAYS

  • IMMUNOASSAY MARKET - MARKET DRIVERS AND CHANGES
  • NEW AND EMERGING AREAS OF IMMUNOASSAY INNOVATION
    • Gastrointestinal Disorders
      • Table 6-1: Selected Inflammatory Bowel Disease Test Innovations
    • Transplant Management
      • Table 6-2: Selected Immunoassays Innovations for Transplant Medicine
    • Preeclampsia
      • Table 6-3: Selected Immunoassays Innovations for Preeclampsia
    • Alzheimer's Disease
      • Table 6-4: Selected Immunoassay Innovations for Alzheimer's Disease
      • Table 6-5: Selected New and Emerging Biomarkers Detected by Immunoassays
      • Table 6-6: Selected Immunoassay Innovations
  • EMERGING INTERNATIONAL MARKETS
    • Table 6-7: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays
  • OUTLOOK FOR IMMUNOASSAYS

7: IMMUNOASSAY MARKET ANALYSIS

  • MARKET OVERVIEW AND MARKET SEGMENTS
    • Table 7-1: Global Immunoassay Market 2014-2021 (in millions % at manufacturer level)
    • Figure 7-1: Global Immunoassay Market Segments by Type of Laboratory Test 2016
    • Central Lab-based Immunoassay Market
      • Table 7-2: Global Lab-based Immunoassay Market 2014-2021 (in millions % at manufacturer level)
    • POC Immunoassay Market
      • Table 7-3: Global POC Immunoassay Market 2014-2021 (in millions % at manufacturer level)
      • Table 7-4: Global POC Immunoassay Testing Market Analysis by Product Category 2016 (in millions $)
      • Figure 7-2: Global POC Immunoassay Testing Market Analysis by Product Category Percent 2016
    • Blood Screening Immunoassay Market
      • Table 7-5: Global Blood Screening Immunoassay Market 2014-2021 (in millions % at manufacturer level)136
    • Immunoassay Market by Product Type
      • Figure 7-3: Global Immunoassay Market Share % by type of product 2016
    • Immunoassay Market by Technology Type
      • Figure 7-4: Global Immunoassay Market Share by Technology (Chemiluminesce, Fluorescence, RIA, ELISA) 2016
  • COMPETITIVE ANALYSIS
    • Table 7-6: Global Immunoassay Market Analysis by Competitor Revenues and Market Share % 2016
    • Figure 7-5: Global Immunoassay Market Analysis by Competitor Market Share % 2016
  • LAB-BASED IMMUNOASSAYS BY DISEASE CATEGORY
    • Table 7-7: Global Lab-based Market Analysis by Disease Category, 2016 (in millions$)
    • Figure 7-6: Global Lab-based Market Analysis by Disease Category, 2016
    • Table 7-8: Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease (in millions$)
    • Figure 7-7: Global Lab-based Infectious Disease Immunoassay Market Share % 2016
    • Table 7-9: Global Lab-based Tumor Marker Immunoassay Sales 2016 (in millions$)
    • Figure 7-8: Global Lab-based Tumor Marker Immunoassay Market Share % 2016
  • POINT OF CARE/RAPID TEST IMMUNOASSAYS BY DISEASE CATEGORY
    • Table 7-10: Global POC Immunoassay Market Analysis by Disease Category, 2016 (in millions$)
    • Figure 7-9: Global POC Immunoassay Market Analysis by Disease Category Market Share %, 2016
  • IMMUNOASSAY MARKET BY GEOGRAPHIC REGIONS
    • Table 7-11: Immunoassay Market by Geographic Region 2016
    • Figure 7-10: Immunoassay Market % by Geographic Region 2016
    • Table 7-12: Immunoassay Market by Geographic Region 2021
    • Figure 7-11: Immunoassay Market % by Geographic Region 2021
    • Europe
      • Table 7-13: Immunoassay Market by European Geographic Region 2016
      • Figure 7-12: Immunoassay Market Share % by European Geographic Region 2016
    • Rest of World
      • Table 7-14: Immunoassay Market by Rest of World Geographic Region 2016
      • Figure 7-13: Immunoassay Market Share % by Rest of World Geographic Region 2016
  • PROGNOSIS FOR GROWTH OF THE IMMUNOASSAY MARKET
    • Table 7-15: Selected New Immunoassay Technologies 2016

8: COMPANY PROFILES

  • 1 STEP DETECT ASSOCIATES, LLC
    • Table 8-1: 1-Step Detect Associates Corporate Summary
    • Company Overview
    • Products
  • ABBOTT LABORATORIES
    • Table 8-2: Abbott Corporate Summary
    • Company Overview
    • Product
    • Company Financials
      • Table 8-3: Abbott Laboratories Revenue (2013-2016) ($ millions)
  • ABINGDON HEALTH, LTD.
    • Table 8-4: Abingdon Health Corporate Summary
    • Company Overview
    • Products
  • ACCESS BIO, INC.
    • Table 8-5: Access Bio Summary
    • Company Overview
    • Products
  • ACCUBIOTECH CO, LTD.
    • Table 8-6: AccuBioTech Summary
    • Company Overview
    • Products
  • ACCUTECH, LLC
    • Table 8-7: Accutech Corporate Summary
    • Company Overview
    • Products
  • ACON LABORATORIES, INC
    • Table 8-8: ACON Laboratories Corporate Summary
    • Company Overview
    • Products
  • AESKU. DIAGNOSTICS
    • Table 8-9: AESKU.DIAGNOSTICS Corporate Summary
    • Company Overview
    • Products
  • AKERS BIOSCIENCES, INC.
    • Table 8-10: Akers Biosciences Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-11: Akers Biosciences (2013-2016) ($ millions)
  • ALERE INC.
    • Table 8-12: Alere Corporate Summary
    • Company Overview
    • Product
    • Company Financials
      • Table 8-13: Alere Revenue (2013-2016) ($ millions)
  • ALFA SCIENTIFIC DESIGNS, INC
    • Table 8-14: Alfa Scientific Designs Summary
    • Company Overview
    • Products
  • AMERICAN LABORATORY PRODUCTS COMPANY (ALPCO)
    • Table 8-15: American Laboratory Products Corporate Summary
    • Company Overview
    • Products
  • AMERICAN BIO MEDICA CORPORATION
    • Table 8-16: American Bio Medica Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-17: American Bio Medica Revenue (2013-2016) ($ thousands)
  • AMNISURE INTERNATIONAL
    • Table 8-18: Amnisure International Corporate Summary
    • Company Overview
    • Products
  • ARK DIAGNOSTICS, INC.
    • Table 8-19: ARK Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ARKRAY, INC.
    • Table 8-20: ARKRAY Corporate Summary
    • Company Overview
    • Products
  • ARLINGTON SCIENTIFIC, INC.
    • Table 8-21: Arlington Scientific Corporate Summary
    • Company Overview
    • Products
  • ARTRON LABORATORIES INC.
    • Table 8-22: Artron Laboratories Corporate Summary
    • Company Overview
    • Products
  • ASSOCIATES OF CAPE COD, INC. (ACC)
    • Table 8-23: Associates of Cape Cod Corporate Summary
    • Company Overview
    • Products
  • ASTRA BIOTECH GMBH
    • Table 8-24: Astra Biotech Corporate Summary
    • Company Overview
    • Products
  • ATLAS GENETICS LTD.
    • Table 8-25: Atlas Genetics Corporate Summary
    • Company Overview
    • Products
  • ATLAS LINK BIOTECH CO., LTD
    • Table 8-26: Atlas Link Biotech Summary
    • Company Overview
    • Products
  • AUDIT DIAGNOSTICS
    • Table 8-27: Audit Diagnostics Corporate Summary
    • Company Overview
    • Products
  • AUGURIX DIAGNOSTIC
    • Table 8-28: Augurix Diagnostic Summary
    • Company Overview
    • Products
  • AUTOBIO DIAGNOSTICS CO., LTD
    • Table 8-29: Autobio Diagnostics Summary
    • Company Overview
    • Products
  • AVIOQ, INC.
    • Table 8-30: Avioq Corporate Summary
    • Company Overview
    • Products
  • AWARENESS TECHNOLOGY
    • Table 8-31: Awareness Technology Corporate Summary
    • Company Overview
    • Products
  • AXA DIAGNOSTICS S.R.L.
    • Table 8-32: AXA Diagnostics Corporate Summary
    • Company Overview
    • Products
  • AXIS SHIELD DIAGNOSTICS LTD.
    • Table 8-33: Axis Shield Corporate Summary
    • Company Overview
    • Products
  • BECKMAN COULTER, INC
    • Table 8-34: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-35: Beckman Coulter (2013-2016) ($ millions)
  • BECTON DICKINSON (BD)
    • Table 8-36: BD Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-37: BD (2013-2016) ($ millions)
  • BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
    • Table 8-38: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
    • Company Overview
    • Products
  • BG MEDICINE, INC.
    • Table 8-39: BG Medicine Corporate Summary
    • Company Overview
    • Products
  • BHAT BIO-TECH INDIA PRIVATE LTD. (BBI)
    • Table 8-40: Bhat Bio-Tech India Private Corporate Summary
    • Company Overview
    • Products
  • BINDING SITE GROUP LTD.
    • Table 8-41: Binding Site Group Corporate Summary
    • Company Overview
    • Products
  • BIOCARE DIAGNOSTICS LTD.
    • Table 8-42: Biocare Diagnostics Corporate Summary
    • Company Overview
    • Productsi
  • BIOCHECK, INC
    • Table 8-43: Biocheck Corporate Summary
    • Company Overview
    • Products
  • BIOHIT OYJ (BIOHIT HEALTHCARE)
    • Table 8-44: Biohit Oyj Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-45: Biohit Oyj (2013-2016) ($ millions)
  • BIOKIT S.A.
    • Table 8-46: Biokit Corporate Summary
    • Company Overview
    • Products
  • BIOLYTICAL LABORATORIES
    • Table 8-47: bioLytical Laboratories Summary
    • Company Overview
    • Products
  • BIOMERICA
    • Table 8-48: Biomerica Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-49: Biomerica (2013-2016) ($ millions)
  • BIOMERIEUX SA
    • Table 8-50: bioMerieux SA Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-51: bioMerieux Revenues (2013-2016) ($ millions)
  • BIOPORTO DIAGNOSTICS
    • Table 8-52: BioPorto Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-53: BioPorto Diagnostics (2013-2016) ($ millions)
  • BIO-RAD LABORATORIES INC
    • Table 8-54: Bio-Rad Labs Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-55: Bio-Rad Labs (2013-2016) ($ millions)
  • BIOSCAN SCREENING SYSTEMS, INC.
    • Table 8-56: Bioscan Screening Systems Corporate Summary
    • Company OverviewProducts
  • BIOSCIENCE (TIANJIN) DIAGNOSTIC TECHNOLOGY CO., LTD.
    • Table 8-57: Bioscience (Tianjin) Diagnostic Technology Corporate Summary
    • Company Overview
    • Products
  • BIOTECH ATLANTIC, INC.
    • Table 8-58: Biotech Atlantic Corporate Summary
    • Company Overview
    • Products
  • BIO-TECHNE
    • Table 8-59: Bio-Techne Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-60: Bio-Techne (2013-2016) ($ millions)
  • BIOTRON DIAGNOSTICS, INC.
    • Table 8-61: Biotron Diagnostics Corporate Summary
    • Company Overview
    • Products
  • BNTX INC.
    • Table 8-62: BTNX Corporate Summary
    • Company OverviewProducts
  • BOSON BIOTECH CO. LTD
    • Table 8-63: Boson Biotechl Summary
    • Company Overview
    • Products
  • BUHLMANN LABORATORIES AG
    • Table 8-64: BUHLMANN Laboratories Summary
    • Company Overview
    • Products
  • CALYPTE BIOMEDICAL CORPORATION
    • Table 8-65: Calypte Biomedical Summary
    • Company Overview
    • Products
  • CARE PRODUCTS, INC.
    • Table 8-66: CARE Products Corporate Summary
    • Company OverviewProducts
  • CERTEST BIOTEC
    • Table 8-67: CerTest Biotec Summary
    • Company Overview
    • Products
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
    • Table 8-68: Chembio Diagnostic Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-69: Chembio Diagnostics Revenues (2013-2016) ($ millions)
  • CISBIO BIOASSAYS
    • Table 8-70: Cisbio Bioassays Corporate Summary
    • Company Overview
    • Products
  • CLARITY DIAGNOSTICS, LLC
    • Table 8-71: Clarity Diagnostics Corporate Summary
    • Company Overview
    • Products
  • CONFIRM BIOSCIENCES
    • Table 8-72: Confirm Biosciences Corporate Summary
    • Company Overview
    • Products
  • CTK BIOTECH, INC.
  • Table 8-73: CTK Biotech Corporate Summary
  • Company Overview
  • Products
  • DIAGENICS LTD.
    • Table 8-74: Diagenics Corporate Summary
    • Company Overview
    • Products
  • DIALAB GMBH
    • Table 8-75: DIALAB Summary
    • Company Overview
    • Products
  • DIAMETRA
    • Table 8-76: Diametra Corporate Summary
    • Company Overview
    • Products
  • DIASORIN S.P.A.
    • Table 8-77: DiaSorin Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-78: DiaSorin (2013-2016) ($ millions)
  • DIASOURCE IMMUNOASSAYS SA
    • Table 8-79: Diasource ImmunoAssays Corporate Summary
    • Company Overview
    • Products
  • DIASYS DIAGNOSTIC SYSTEMS GMBH
    • Table 8-80: DiaSys Diagnostic Systems Corporate Summary
    • Company Overview
    • Products
  • DIAXOHIT
    • Table 8-81: Diaxohit Corporate Summary
    • Company Overview
    • Products
  • DIAZYME LABORATORIES, INC.
    • Table 8-82: Diazyme Laboratories Corporate Summary
    • Company Overview
    • Products
  • DR. FOOKE-ACHTERRATH LABORATORIEN GMBH
    • Table 8-83: Dr. Fooke-Achterrath Laboratorien Corporate Summary
    • Company Overview
    • Products
  • DRG INTERNATIONAL, INC.
    • Table 8-84: DRG International Corporate Summary
    • Company Overview
    • Products
  • EIKEN CHEMICAL CO LTD.
    • Table 8-85: Eiken Chemical Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-86: Eiken Chemical Revenue (2013-2016) ($ millions)
  • EKF DIAGNOSTICS HOLDINGS PLC
    • Table 8-87: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-88: EKF Diagnostics Revenue (2013-2016) ($ millions)
  • ELITECHGROUP, INC.
    • Table 8-89: ELITechGroup Corporate Summary
    • Company Overview
    • Products
  • ERBA DIAGNOSTICS, INC.
    • Table 8-90: ERBA Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-91: ERBA Diagnostics (2013-2016) ($ millions)
  • EUROIMMUN AG
    • Table 8-92: Euroimmun AG Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-93: EUROIMMUN Revenue (2013-2016) ($ millions)
  • EUROSPITAL S.P.A.
    • Table 8-94: Eurospital Summary
    • Company Overview
    • Products
  • EY LABORATORIES
    • Table 8-95: EY Laboratories Summary
    • Company Overview
    • Products
  • FIRST CHECK DIAGNOSTICS LLC
    • Table 8-96: First Check Diagnostics Corporate Summary
    • Company Overview
    • Products
  • FUJIREBIO US, INC.
    • Table 8-97: Fujirebio Corporate Summary
    • Company Overview
    • Products
  • GENBIO
    • Table 8-98: GenBio Corporate Summary
    • Company Overview
    • Products
  • GETEIN BIOMEDICAL, INC.
    • Table 8-99: GeTein Corporate Summary
    • Company Overview
    • Products
  • GLYSBY SNC
    • Table 8-100: GlysBy Corporate Summary
    • Company Overview
    • Products
  • GOLD STANDARD DIAGNOSTICS
    • Table 8-101: Gold Standard Diagnostics Corporate Summary
    • Company Overview
    • Products
  • GRIFOLS INTERNATIONAL S.A.
    • Table 8-102: Grifols International S.A. Corporate Summary
    • Company Overview
    • ProductsCompany Financials
      • Table 8-103: Grifols (2013-2016) ($ millions)
  • HEMA DIAGNOSTIC SYSTEMS, LLC
    • Table 8-104: Hema Diagnostics Systems Corporate Summary
    • Company Overview
    • Products
  • HEMOSURE, INC.
    • Table 8-105: Hemosure Corporate Summary
    • Company Overview
    • Products
  • HOB BIOTECH
    • Table 8-106: HOB Biotech Corporate Summary
    • Company Overview
    • Products
  • HYCOR BIOMEDICAL, INC.
    • Table 8-107: HYCOR Biomedical Corporate Summary
    • Company Overview
    • Products
  • IMMUNODIAGNOSTIC SYSTEMS LTD. (IDS)
    • Table 8-108: Immunodiagnostic Systems Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-109: IDS (2013-2016) ($ millions)
  • IMMUNO-MYCOLOGICS, INC.
    • Table 8-110: Immuno-Mycologics Corporate Summary
    • Company Overview
    • Products
  • IMMUNOSCIENCES LAB, INC.
    • Table 8-111: Immunosciences Lab Corporate Summary
    • Company Overview
    • Products
  • IMMUNOSTICS, INC
    • Table 8-112: Immunostics Corporate Summary
    • Company Overview
    • Products
  • INBIOS INTERNATIONAL, INC.
    • Table 8-113: InBios Corporate Summary
    • Company Overview
  • INOVA DIAGNOSTICS, INC
    • Table 8-114: Inova Diagnostics Corporate Summary
    • Company Overview
    • Products
  • JANT PHARMACAL CORPORATION
    • Table 8-115: Jant Pharmacal Summary
    • Company Overview
    • Products
  • KRONUS
    • Table 8-116: Kronus Corporate Summary
    • Company Overview
    • Products
  • LABSYSTEMS DIAGNOSTICS OY
    • Table 8-117: Labsystems Diagnostics Corporate Summary
    • Company Overview
    • Products
  • LIFESIGN, LLC
    • Table 8-118: LifeSign Summary
    • Company Overview
  • LUMINEX CORPORATION
    • Table 8-119: Luminex Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-120: Luminex (2013-2016) ($ millions)
  • MEDIX BIOCHEMICA
    • Table 8-121: Medix Biochemica Summary
    • Company Overview
    • Products
  • MEDMIRA, INC
    • Table 8-122: MedMira Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-123: MedMira. (2013-2016) ($ millions)
  • MERCODIA AB
    • Table 8-124: Mercodia AB Summary
    • Company Overview
    • Products
  • MERIDIAN BIOSCIENCE, INC
    • Table 8-125: Meridian BioScience Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-126: Meridian Bioscience Revenue (2013-2016) ($ millions)
  • MONOBIND, INC
    • Table 8-127: Monobind Corporate Summary
    • Company Overview
    • Products
  • NANO-DITECH CORPORATION
    • Table 8-128: Nano-Ditech Corporate Summary
    • Company Overview
    • Products
  • NOVA BIOMEDICAL, CORP.
    • Table 8-129: Nova Biomedical Corporate Summary
    • Company Overview
    • Products
  • NOVATEC IMMUNODIAGNOSTICA GMBH
    • Table 8-130: Novatec Immunodiagnostica Corporate Summary
    • Company Overview
    • Products
  • OASIS DIAGNOSTICS CORPORATION
    • Table 8-131: Oasis Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ONCIMMUNE HOLDINGS PLC.
    • Table 8-132: Oncimmune Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-133: Oncimmune Revenue (2013-2016) ($ millions)
  • ONE LAMBDA
    • Table 8-134: One Lambda Corporate Summary
    • Company Overview
    • Products
  • OPERON
    • Table 8-135: Operon Corporate Summary
    • Company Overview
    • Products
  • OPKO HEALTH, INC
    • Table 8-136: OPKO Health Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-137: OPKO Health Revenue (2013-2016) ($ millions)
  • ORASURE TECHNOLOGIES, INC.
    • Table 8-138: OraSure Technologies Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-139: OraSure Revenue (2013-2016) ($ millions)
  • ORGENTEC DIAGNOSTIKA GMBH
    • Table 8-140: Orgentec Diagnostika Corporate Summary
    • Company Overview
    • Products
  • ORION DIAGNOSTICA OY
    • Table 8-141: Orion Diagnostica Corporate Summary
    • Company Overview
    • Products
  • ORTHO CLINICAL DIAGNOSTICS
    • Table 8-142: Ortho Clinical Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-143: Ortho Clinical Diagnostics Revenue (2013-2016) ($ millions)
  • POLYMEDCO, INC
    • Table 8-144: Polymedco Corporate Summary
    • Company Overview
    • Products
  • QUALIGEN, INC.
    • Table 8-145: Qualigen Corporate Summary
    • Company Overview
    • Products
  • QUANTERIX CORPORATION
    • Table 8-146: Quanterix Corporate Summary
    • Company Overview
    • Products
  • QUIDEL CORPORATION
    • Table 8-147: Quidel Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-148: Quindel Revenue (2013-2016) ($ millions)
  • PREVENTIS GMBH
    • Table 8-149: Preventis Corporate Summary
    • Company Overview
    • Products
  • PRINCETON BIOMEDITECH CORPORATION
    • Table 8-150: Princeton Biomeditech Corporate Summary
    • Company Overview
    • Products
  • PROTAGEN AG
    • Table 8-151: Protagen Corporate Summary
    • Company Overview
    • Products
  • RADIOMETER MEDICAL A/S
    • Table 8-152: Radiometer Medical Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-153: Radiometer Revenue (2013-2016) ($ millions)
  • RANDOX LABORATORIES LTD.
    • Table 8-154: Randox Laboratories Corporate Summary
    • Company Overview
    • Products
  • RELIA DIAGNOSTICS, INC
    • Table 8-155: ReLia Diagnostics Corporate Summary
    • Company Overview
    • Products
  • RENESA UG
    • Table 8-156: RENESA UG Corporate Summary
    • Company Overview
    • Products
  • RESPONSE BIOMEDICAL CORP
    • Table 8-157: Response Biomedical Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-158: Response Biomedical Revenue (2013-2016) ($ millions)
  • RESZON DIAGNOSTICS INTERNATIONAL SDN. BHD.
    • Table 8-159: Reszon Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ROCHE DIAGNOSTIC CORPORATION
    • Table 8-160: Roche Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-161: Roche Revenue (2013-2016) ($ millions)
  • SAVYON DIAGNOSTICS LTD.
    • Table 8-162: Savyon Diagnostics Summary
    • Company Overview
    • Products
  • SEKISUI DIAGNOSTICS
    • Table 8-163: Sekisui Diagnostics Summary
    • Company Overview
    • Products
  • SIEMENS HEALTHINEERS
    • Table 8-164: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-165: Siemens Healthineers Revenue (2013-2016) ($ millions)
  • SINGULEX, INC
    • Table 8-166: Singulex Corporate Summary
    • Company Overview
    • Products
  • STANDARD DIAGNOSTICS, INC.
    • Table 8-167: Standard Diagnostics Corporate Summary
    • Company Overview
    • Products
  • SYNTRON BIORESEARCH, INC.
    • Table 8-168: Syntron Bioresearch Corporate Summary
    • Company Overview
    • Products
  • TECHLAB, INC.
    • Table 8-169: TECHLAB Corporate Summary
    • Company Overview
    • Products
  • TECO DIAGNOSTICS
    • Table 8-170: Teco Diagnostics Corporate Summary
    • Company Overview
    • Products
  • THERADIAG
    • Table 8-171: Theradiag Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-172: Theradiag (2013-2016) ($ millions)
  • THERMO FISHER SCIENTIFIC, INC
    • Table 8-173: Thermo Fisher Scientific Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-174: Thermo Fisher Scientific (2013-2016) ($ millions)
  • TOSOH BIOSCIENCE, INC.
    • Table 8-175: Tosoh Bioscience Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-176: Tosoh Corporation (2013-2016) ($ millions)
  • TRINITY BIOTECH PLC
    • Table 8-177: Trinity Biotech Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-178: Trinity Biotech Revenue (2013-2016) ($ millions)
  • TRUE DIAGNOSTICS
    • Table 8-179: True Diagnostics Corporate Summary
    • Company Overview
    • Products
  • VIRCELL
    • Table 8-180: Vircell Corporate Summary
    • Company Overview
    • Products
  • VOLITIONRX LIMITED
    • Table 8-181: VolitionRx Corporate Summary
    • Company Overview
    • Products
  • WAKO DIAGNOSTICS
    • Wako Life Sciences
      • Table 8-182: Wako Diagnostics Corporate Summary
    • Company Overview
    • Products
  • WAMA DIAGNOSTICA
    • Table 8-183: WAMA Diagnostica Corporate Summary
    • Company Overview
    • Products
  • WERFEN GROUP
    • Table 8-184: Werfen Group Corporate Summary
    • Company Overview
  • ZEUS SCIENTIFIC, INC.
    • Table 8-185: Zeus Scientific Corporate Summary
    • Company Overview
    • Products
Back to Top